Join us on September 22nd, 2026 at BioCity, Nottingham as we bring together leaders from academia, biotech, and pharma as we explore how an integrated discovery‑to‑development mindset, linking translational science with modality‑aware developability, can accelerate the journey from early hypotheses to clinical development. Discover the tools, technologies, and approaches that help turn innovative concepts into viable therapeutic candidates, with a spotlight on emerging modalities.
Key topics will include:
- Bridging discovery to development
- Translational biology and biomarkers
- New developments in TPDs and oligonucleotides
- Designing for developability across modalities
- Platform thinking and tech transfer
Click here or click the ‘Get More Information’ button to register an interest.Please note that registration does not guarantee attendance. All registrations will be reviewed, and confirmed guests will receive an official confirmation email. We kindly ask that you wait for this confirmation before making any travel arrangements.


